NEFL and myeloid sarcoma: Despite controversial relevance in neurological progression, recent clinical studies reported higher serum NfL levels in MS patients than in healthy individuals in relation to disease progression, potentially highlighting the detection of NfL levels as an ancillary diagnostic tool for MRI-detected lesions [174,175].